Abstract |
We evaluated the percent of acute respiratory viral infections with gastrointestinal syndrome in the structure of morbidity in babies aging 6 months and elder. Therapeutic efficiency and safety of anaferon (pediatric formuation) as a component of complex therapy of acute respiratory viral infections with involvement of the gastrointestinal tract were proven; more rapid disappearance of all symptoms and improvement of the immune status parameters were demonstrated.
|
Authors | E A Dondurei, L V Osidak, E G Golovacheva, A K Golovanova, I V Amosova, L N Gladchenko |
Journal | Bulletin of experimental biology and medicine
(Bull Exp Biol Med)
Vol. 148
Issue 2
Pg. 283-6
(Aug 2009)
ISSN: 1573-8221 [Electronic] United States |
PMID | 20027348
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antibodies
- Antiviral Agents
- Interferon Inducers
- anaferon
|
Topics |
- Antibodies
(therapeutic use)
- Antiviral Agents
(therapeutic use)
- Child, Preschool
- Female
- Gastrointestinal Diseases
(drug therapy, virology)
- Humans
- Infant
- Interferon Inducers
(therapeutic use)
- Male
- Respiratory Tract Infections
(drug therapy, virology)
- Treatment Outcome
- Virus Diseases
(drug therapy, virology)
|